Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine in heart failure with preserved ejection fraction
ChiCTR-IIR-17013377Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ivabradine in heart failure with preserved ejection fraction (HFpEF) and chronic heart failure (CHF) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Peak oxygen consumption. Started Dec 2017; status: recruiting.
02
Drugs
ivabradine
03
Conditions
heart failure with preserved ejection fraction (HFpEF)chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR-IIR-17013377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17013377.